Abstract     Description     Claims     Drawing  

Cancer statistics   [0002] 
Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment   [0002] 
Estimates of the worldwide mortality from 25 cancers in 1990   [0002] 
Risk of bladder cancer by source and type of tobacco exposure: a case-control study   [0003] 
The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review   [0003] 
Molecular profiling of bladder cancer using cDNA microarrays: defining histogenesis and biological phenotypes   [0005]  [0010] 
Genetic initiation, progression and prognostic markers in transitional cell carcinoma of the bladder: a summary of the structural and transcriptional changes, and the role of developmental genes   [0005] 
Metastases from transitional cell carcinoma of urinary bladder   [0005] 
What we could do now: molecular pathology of bladder cancer   [0006] 
DNA-based molecular cytology for bladder cancer surveillance   [0007] 
The accuracy of urinary cytology in daily practice   [0007] 
Can urine bound diagnostic tests replace cystoscopy in the management of bladder cancer?   [0008] 
Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment   [0008] 
A multicenter trial evaluation of the fibrin/fibrinogen degradation products test for detection and monitoring of bladder cancer   [0008] 
Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer   [0008] 
A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine   [0008] 
Detection of telomerase activity in prostate cancer by needle biopsy   [0008] 
Comparison of bladder washings and urine cytology in the diagnosis of bladder cancer   [0008] 
Non-invasive diagnostic tests for bladder cancer: a review of the literature   [0008] 
Expression profiling using cDNA microarrays   [0010] 
Expression profiling: DNA arrays in many guises   [0010] 
Multiclass cancer diagnosis using tumor gene expression signatures   [0010] 
Gene discovery in bladder cancer progression using cDNA microarrays   [0010] 
Tumor suppressor role of KiSS-1 in bladder cancer: loss of KiSS-1 expression is associated with bladder cancer progression and clinical outcome   [0010] 
Identifying distinct classes of bladder carcinoma using microarrays   [0010] 
Uroplakin gene expression in normal human tissues and locally advanced bladder cancer   [0010] 
A quantitative reverse transcription and polymerase chain reaction assay for human IGF-II allows direct comparison of IGF-II mRNA levels in cancerous breast, bladder, and prostate tissues   [0010] 
Four tumor suppressor loci on chromosome 9q in bladder cancer: evidence for two novel candidate regions at 9q22.3 and 9q31.   [0010] 
Neural network using combined urine nuclear matrix protein-22, monocyte chemoattractant protein-1 and urinary intercellular adhesion molecule-1 to detect bladder cancer   [0014] 
Comparison of cytokeratin 20 RNA and angiogenin in voided urine samples as diagnostic tools for bladder carcinoma   [0014] 
Allelic deletion fingerprinting of urine cell sediments in bladder cancer   [0014] 
Tumours of the Urinary System   [0101] 
TNM Classification of Malignant Tumours   [0101] 
A new strategy to amplify degraded RNA from small tissue samples for microarray studies   [0101] 
Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces   [0103] 
A new strategy to amplify degraded RNA from small tissue samples for microarray studies   [0105] 
Comparison of fluorescent tag DNA labeling methods used for expression analysis by DNA microarrays   [0105]